| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |